PISCATAWAY, N.J. – Camber Pharmaceuticals announced the addition of acyclovir oral suspension to its current portfolio.
Acyclovir oral suspension is a synthetic nucleoside analogue active against herpes viruses. Acyclovir oral suspension from Camber is available in 200 mg/5 mL strength in 473 mL bottles.
Comments are closed.